ChemoCare Goes Live across NHS Scotland

ChemoCare Goes Live across NHS Scotland

ChemoCare, the new electronic chemotherapy prescribing and patient scheduling system known in NHS Scotland as CEPAS has successfully gone live across all three of the Scottish Cancer Networks - South East Scotland (SCAN), North of Scotland (NOSCAN) and West of Scotland (WoSCAN).

ChemoCare provides support for safe prescribing and administration, giving each patient a single electronic chemotherapy treatment record that is accessible to designated members of the multi-professional team across the pathways of care and from multiple geographical points of service delivery. Key to the functionality of ChemoCare is ChemoSchedule, the integrated patient scheduling system which enables clinical staff to manage both resource and chair allocation for patients receiving chemotherapy within and across hospitals whilst ensuring that appointment dates align with prescribed cycles of treatment. It also allows for the movement of patients as they occur in clinical practice (within and between cycles).

The Beatson West of Scotland Cancer Centre (BWoSCC) in Glasgow was first to implement CEPAS and has now been running in a live environment since December 2010. The BWoSCC was closely followed by go lives across the WoSCAN sites of the New Victoria Ambulatory Care Hospital, Southern General Hospital, Vale of Leven Hospital, Inverclyde Royal Hospital in NHS Greater Glasgow & Clyde. The Go Lives then continued at pace across a further 6 sites and 4 NHS Boards:

·         Royal Alexandra Hospital, Paisley

·         Ayr Hospital

·         Forth Valley General Hospital, Larbert

·         Wishaw General Hospital

·         Monklands General Hospital, Airdrie

·         Hairmyres Hospital, East Kilbride

The remaining 2 sites within WoSCAN, Crosshouse Hospital, Kilmarnock and Glasgow Royal Infirmary are planned to go live in summer 2012, completing roll out of CEPAS to all sites administering chemotherapy in WoSCAN.

Evelyn Thomson, Regional Manager (Cancer) of the West of Scotland Cancer Network said “The West of Scotland Cancer Network aims to achieve real improvements in the delivery of patient centred systemic anti cancer therapy services across the 4 NHS Boards in the region. The implementation of ChemoCare as a single patient database supports that aim. It supports the safe delivery of care as close to home as possible. ChemoCare will also help us monitor the uptake of cancer medicines more effectively and better understand clinical outcomes. There have been significant challenges in developing and implementing what is be the largest networked electronic chemotherapy prescribing solution in the UK but the effort is worthwhile because of the benefits that we expect this system will bring for patients across the west of Scotland. This has been possible through collaborative working with CIS Oncology, the dedication and commitment of the NHS Project Team and staff within our partner Boards”.

In parallel, SCAN has implemented scheduling and prescribing in all boards and is in the process of rolling out ChemoCare to all tumour types. The rollout started at the Western General Hospital in Edinburgh in March 2011 and SCAN has now successfully started ChemoCare implementation at a further 6 sites: 

  • St John's Hospital, Livingston
  • Queen Margaret Hospital, Dunfermline
  • Victoria Hospital, Kirkcaldy
  • Borders General Hospital, Melrose
  • Dumfries and Galloway Royal Infirmary
  • Galloway Community Hospital, Stranraer  

Dr Val Doherty, SCAN's Clinical Director , said: “Electronic prescribing of chemotherapy (CEPAS ) will allow SCAN to continue to achieve its aim of providing safe and effective drug treatments for all cancer patients. This approach will help offset the challenges of increasing cancer incidence and the introduction of new, more complex chemotherapy regimes. Nursing, medical, pharmacy and IT colleagues from across the region have worked with great dedication and enthusiasm to introduce ChemoCare, which represents a significant change in practice. We look forward to the full rollout of the system to all tumour types in the near future and welcome this opportunity to further enhance our service to our patients.”

NOSCAN chose to implement CEPAS in a way which matches their patient flow resulting in three smaller networked solutions. The first across Aberdeen Royal Infirmary and Dr Grays Hospital, Elgin went live in March this year. The second network hosted by the Raigmore Hospital, Inverness has also gone live across 4 additional hospitals:

·         Dr Mackinnon Memorial Hospital

·         Caithness General Hospital

·         Belford Hospital

·         Western Isles Hospital 

The third network is hosted by Ninewells Hospital, Dundee with patients also being treated at Perth Royal Infirmary. This implementation is anticipated to go live in July.